Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-31

FDA Approved: NUVARING — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for Nuvaring (etonogestrel and ethinyl estradiol) by Advanz Pharma (US) Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nuvaring (etonogestrel and ethinyl estradiol)

Snippet

SUPPL AP for NUVARING (ETONOGESTREL AND ETHINYL ESTRADIOL)